Latest Content

A Cancer Survivor Embraces a New Career as a ‘Sit-Down Comedian’

February 21st 2021, 7:00pm

By Ron Cooper


“Did you hear the one about the cancer procedure that went terribly wrong?” “It turned out to be a ‘bi-oopsie!’”

CEO, Breast Cancer Survivor Discusses New Gel to Improve Sexual Quality of Life in Patients with Cancer

February 21st 2021, 4:00pm

By Jessica Skarzynski


Breast cancer survivor and Evofem Biosciences founder and CEO Saundra Pelletier shares her thoughts on a new hormone-free contraceptive gel that could improve sexual quality of life in patients with cancer.

Living with Cancer, Not Dying of It

February 20th 2021, 7:00pm

By Jane Biehl Ph.D.


A cancer survivor offers some statistics about the longevity of cancer survivors.

Above the Surface: A Discussion About Cutaneous T-Cell Lymphoma

February 20th 2021, 2:00pm

By Kristie L. Kahl


As part of its Speaking Out video series, CURE® spoke with Dr. Steven M. Horwitz on behalf of the Cutaneous Lymphoma Foundation about cutaneous T-cell lymphoma and options for treatment.

‘Knowledge is Power’: Advocating for More Representation in Cancer-Related Clinical Trials

February 19th 2021, 10:00pm

By Ryan McDonald


There are several health equity barriers in patients with cancer, one of which involves adequate access to clinical trials. Here, a panel of experts and a cancer survivor discuss ways to improve access.

A ‘T-ALL’ Order: Treating T-Cell Acute Lymphoblastic Leukemia

February 19th 2021, 8:00pm

By Erik Ness


Oncologists and researchers are racing to identify new therapies to help better treat a rare form of acute lymphoblastic leukemia.

No Two Cancer Survivors Are Exactly Alike

February 19th 2021, 5:00pm

By Danielle Ripley-Burgess


Cancer survivors are just like snowflakes in that they are unique and not the same, says a two-time cancer survivor.

Friday Frontline: First Patient to Receive CAR-T Cell Therapy Dies, Cancer Organizations Appeal to President for COVID-19 Vaccine Priority Access, and More

February 19th 2021, 4:00pm

By Jessica Skarzynski


From the death of Bill Ludwig, the first patient to receive CAR-T cell therapy to treat his end-stage CLL, to a letter to the President urging him to grant patients with cancer and survivors priority access to the COVID-19 vaccine, here’s what’s happening in the cancer space this week.

Examining Racial and Ethnic Disparities in Cancer Care

February 19th 2021, 2:00pm

By Debu Tripathy


The past year has spotlighted racial inequities not only in the U.S., but worldwide. It has also opened our eyes as to how a major health disruption — in this case, a pandemic — can aggravate the unacceptable status quo.

Jim’s Story with Chronic Lymphocytic Leukemia (CLL)

February 19th 2021, 1:00pm

By Sponsored Content


Treating CLL with CALQUENCE® (acalabrutinib)

National Organization Recommends Women Delay Mammogram Screening Following COVID-19 Vaccine

February 18th 2021, 8:27pm

By Ryan McDonald


The Society of Breast Imaging has recommended women wait four to six weeks after receiving their second dose of a COVID-19 vaccine to get a screening mammogram. However, experts differ on whether women should wait to get a screening mammogram following their vaccine.

If I Can Face Cancer, I Can Face Anything

February 18th 2021, 5:00pm

By Darlene Benson


Within a short period of time, Darlene Benson lost her dog, brother-in-law, and some of her best friends. But, at the same time, she conquered cancer. She says that if she can face that, she can face anything.

Bob Dole Announces Lung Cancer Diagnosis

February 18th 2021, 4:45pm

By Darlene Dobkowski, MA


Former longtime Kansas senator Bob Dole announced that he will be undergoing treatment for lung cancer next week.

Juggling a Career and Navigating Cancer Treatment

February 18th 2021, 4:00pm

By Ryan McDonald


This week on the “CURE® Talks Cancer” podcast, we spoke with Evofem Biosciences founder and CEO Saundra Pelletier about what it was like to go through the shock of receiving a cancer diagnosis while also navigating a career, and explaining how her product, which is now FDA-approved, can help patients with cancer and survivors improve their sexual quality of life.

Cabometyx Significantly Prolongs Survival Over Sutent in Rare Form of Kidney Cancer

February 18th 2021, 2:00pm

By Ryan McDonald


The study results, according to one expert, show that Cabometyx should be considered the new standard for systemic therapy in patients with metastatic papillary renal cell carcinoma.